Healthcare AI can fail hard under attack - even when it looks fine in normal testing.
If I had to boil this article down to a few points, it would be this:
- Imaging models that score 95%+ on clean data can drop near 25% under pixel-level attacks.
- EHR risk models can be pushed off course by small chart changes, with results like AUC falling from 0.86 to 0.51.
- Medical chatbots can be pushed into unsafe answers, with prompt injection working in 94.4% of simulated patient conversations.
- Hospital AI risk is not just about the model. It also shows up in data pipelines, devices, vendors, and downtime events.
In other words: good baseline performance is not enough. If you work in a hospital, health system, or integrated healthcare risk operations or vendor review team, you need to test the model, the workflow, and the connected systems together.
Here’s the short version of what these case studies show:
- Medical imaging AI: small image changes can flip outputs and move model attention away from the finding
- EHR risk tools: slight changes to codes, labs, or timing can change who gets flagged
- Clinical chatbots and LLMs: prompts can bypass safeguards and trigger harmful advice
- Hospital infrastructure: weak segmentation, poisoned data, device tampering, and ransomware can break AI-dependent care flows
Adversarial Attacks on Healthcare AI: Key Failure Rates & Impact
Trusted CI Webinar: Securing Medical Imaging AI Models Against Adversarial Attacks
sbb-itb-535baee
Quick Comparison
| Area tested | Main attack path | What happened | What teams changed |
|---|---|---|---|
| Imaging AI | FGSM / PGD image perturbations | Accuracy drops as low as 7.65%–25.32% in some tests | Adversarial training, review gates, detection checks |
| EHR risk models | Input manipulation, poisoning | Accuracy fell from 86% to 57%; AUC from 0.86 to 0.51 | Data audits, cutoff review, extra validation |
| Medical chatbots | Prompt injection, prompt mutation | Unsafe or problematic replies in 5%–43.2% of cases; injection success at 94.4% | Human review, stricter limits, red-team tests |
| Hospital AI systems | Network access, pipeline tampering, device compromise, ransomware | Delayed, corrupted, or missing AI inputs that can affect care | Cross-team ownership, vendor tracking, remediation workflows |
What I like about these examples is that they stay focused on one question: what failed, how bad it got, and what changed after the test. That makes the article useful for security, compliance, IT, and clinical governance teams that need a clean record of risk, response, and retesting.
Case study 1: Adversarial testing in medical imaging AI
Medical imaging AI sits inside high-stakes clinical work. It can affect decisions about nodule detection, hemorrhage triage, and more. In PACS-linked workflows, an attacker doesn't need to alter the visible PACS image to cause harm. They can go after the DICOM gateway, inference API, appliance, or workstation cache instead. That makes the image path a practical place to test adversarial risk, not just an academic edge case.
How FGSM and PGD attacks changed imaging model outputs
FGSM and PGD drove sharp accuracy drops across imaging tasks.
The numbers from research are hard to ignore. A DenseNet-121 chest imaging model reached 95.42% accuracy on clean data. Under PGD with ε = 0.1/255, that fell to 25.32% - about a 70-point drop.[3] In a multi-modality cancer imaging study, PGD cut accuracy on lung nodule X-ray to 40%, leukemia microscopy to 36%, and brain MRI to 77%.[4] For CT, mammogram, and brain MRI classifiers tested with a perturbation size of 0.004, accuracy dropped to 25.6%, 23.9%, and 7.65%, respectively.[5]
At that point, we're not talking about a small dip in model quality. We're talking about failure rates that can make a diagnostic model unsafe.
PGD can also pull model attention away from the lesion and toward background artifacts.[3] In a triage setting, that could push missed hemorrhages lower in the worklist or mark benign screenings as urgent. That's the kind of shift that turns a model problem into a patient safety problem fast.
The scale of these drops shows why robustness controls belong in deployment planning. They aren't just a nice extra for model tuning.
What the simulations revealed about safety and controls
The clearest takeaway from these simulations is simple: high clean-data AUC does not mean a model will hold up under attack. Adversarial training delivered the strongest gains, while preprocessing and detection gave narrower protection that depended on the task.
For risk and governance teams, the big issue is straightforward: which controls lower risk enough to support deployment?
| Attack technique | Target task | Observed impact | Control response |
|---|---|---|---|
| PGD (ε = 0.1/255) | Chest X-ray (DenseNet-121) | Accuracy: 95.42% → 25.32%[3] | Adversarial training; attention map monitoring |
| PGD (ε = 0.004) | CT / mammogram / brain MRI | Accuracy: 25.6% / 23.9% / 7.65%[5] | Adversarial training; adversarial example detection |
| FGSM | Lung nodule X-ray / leukemia microscopy / brain MRI | Accuracy: 35% / 66% / 70%[4] | Input preprocessing; human-in-the-loop triage review |
| PGD | Lung nodule X-ray / leukemia microscopy / brain MRI | Accuracy: 40% / 36% / 77%[4] | Input preprocessing; human-in-the-loop triage review |
| FGSM + PGD | Brain MRI | FGSM: 32% → 54%; PGD: 13% → 47%[2] | Adversarial training + feature squeezing |
For governance teams, the practical implication is clear: third-party vendor risk robustness claims need to be checked, not just accepted at face value. And that check can't stop at clean test sets. It needs structured adversarial testing too. Censinet RiskOps™ can help teams document adversarial findings in third-party and enterprise risk assessments, along with residual-risk decisions.
Case study 2: Adversarial manipulation of EHR risk prediction and clinical chatbots
EHR-based risk models and clinical chatbots face a different kind of risk than imaging AI. Simulated attacks can expose failure points in both - and push governance teams to act. For EHR models, the weak spots are structured fields like diagnosis codes, procedure codes, medication histories, and timing patterns. For chatbots, the weak spot is plain language prompts.
Both systems sit in high-stakes settings. A changed risk score can affect who gets escalated for care. A bad chatbot reply can steer a patient the wrong way.
How simulated EHR input changes altered risk scores
Black-box attacks on EHR models don't need access to model weights or system design. Testers can make clinically plausible changes - adding, removing, or reordering codes, or shifting when events appear - and then watch the score move. In many closed systems, teams only see the final output, so repeated probing is the only practical way to learn what the model reacts to. The aim is simple: push the result across the clinical cutoff that changes action.
Research shows this is not just a lab exercise. For a Graph Convolutional Transformer (GCT) model trained on MIMIC-III and eICU, FGSM and JSMA attacks cut test accuracy from 86% to about 57% and pushed AUC from 0.86 to 0.51.[6] That's a steep drop in prediction quality. In a separate line of work, poisoning fewer than 5% of EHR training records with subtle trigger patterns produced average attack success rates of 97% on mortality prediction tasks, while the poisoned records still looked statistically similar to normal records and were hard to spot.[7]
Some attacks focus on the exact events most likely to move a score. If one code added to a chart can move a patient from routine monitoring to urgent review, that model is fragile and needs deeper validation before launch.
The same kind of fragility shows up in chatbots. One prompt can shift behavior just as one code change can move a risk score.
How prompt-based attacks exposed unsafe chatbot behavior
Medical LLMs and patient-facing chatbots introduce a different failure mode: language becomes the attack path. Clinician-led red teaming and prompt mutation tests have shown unsafe recommendations, not just inaccurate answers.
A controlled simulation of 216 patient–LLM dialogues found that prompt-injection attacks worked in 102 of 108 trials (94.4%), including 33 of 36 extremely high-harm scenarios (91.7%) - cases involving contraindicated drugs in pregnancy, dangerous drug combinations, and inappropriate controlled substances.[1][9] In a separate set of tests, reviews of patient-facing chatbots, including Claude and Llama, found problematic responses in 21.6–43.2% of cases and unsafe responses in 5–13%, depending on the model.[8] Clinician red teaming of ChatGPT variants across 382 unique prompts found 19.8% of responses labeled inappropriate, with GPT-3.5 doing worst at 25.7%.[10]
Prompt mutation testing pushed on smaller wording shifts: changing age, sex, or pregnancy status, adding ambiguity, or rewriting questions in slang or adversarial phrasing. The result was inconsistent advice driven by surface wording instead of clinical meaning. That's not just a quality gap. It's a safety issue.
What governance teams changed after these simulations
These results called for operating controls, not just model tweaks.
| Scenario | Attack method | Observed effect | Governance response |
|---|---|---|---|
| EHR mortality prediction (GCT model, MIMIC-III/eICU) | FGSM / JSMA | AUC 0.86 → 0.51; accuracy 86% → 57%[6] | Threshold review before deployment; additional validation |
| Poisoned EHR training data (mortality prediction, MIMIC-III) | Backdoor poisoning (<5% of records) | 97% attack success rate[7] | Training data audits; anomaly detection for score volatility |
| Medical LLM patient dialogues | Prompt injection | 94.4% attack success; 91.7% in high-harm scenarios[1][9] | Mandatory escalation guardrails; restricted production use cases |
| Patient-facing chatbots (Claude, Llama) | Prompt mutation / adversarial prompts | Problematic responses in 21.6–43.2% of cases; unsafe responses in 5–13%[8] | Human review for high-risk outputs; demographic consistency testing |
| ChatGPT variants | Clinician red teaming / adversarial prompts | 19.8% inappropriate responses; GPT-3.5 at 25.7%[10] | Documented failure taxonomy; red teaming before and after deployment |
One issue sits underneath all of this: ownership. Someone has to monitor abuse. Someone has to decide what happens when the model is uncertain, inconsistent, or plainly outside its lane.
Case study 3: AI red teaming in hospital infrastructure and vendor-connected systems
Model-level testing - like FGSM attacks on imaging AI or prompt injection against clinical chatbots - shows whether a model fails under pressure. Infrastructure-level red teaming shows whether the systems around the model can be used to make it fail.
NIST draws a line between AI model red teaming and AI system red teaming. In hospitals, that distinction matters. AI tools rely on EHR integrations, imaging archives, device telemetry, and vendor platforms. So the issue isn't just model accuracy. It's whether the surrounding environment can be turned into an attack path.
How infrastructure-level simulations exposed AI workflow risk
Red team exercises in connected hospital environments have shown four attack paths that keep coming up - and each one can affect AI workflow safety.
First, testers used public-facing assets to get into systems that support AI workflows. When AI inference servers, medical devices, and general-purpose endpoints sat on a poorly segmented network, testers could move from an external foothold to internal systems tied to AI pipelines in only a few steps.[11][12] Once inside, they could delay or corrupt the data feeding clinical decision support.
Second is data pipeline tampering. Studies show that attackers with access to as few as 100 to 500 poisoned training records can compromise healthcare AI systems, with attack success rates of 60% or more. In many cases, the performance drop is subtle enough to spread through clinical workflows before anyone notices.[16] In practice, that can skew AI-driven workflows such as sepsis alerts, imaging triage, and discharge risk prediction.[12][13]
Third, connected medical devices create another opening. A documented case study of a blood glucose monitoring system (BGMS) found that attackers who compromised Bluetooth communications between a continuous glucose monitor and its mobile app could alter sensor data. The ML-based decision component then misdiagnosed the patient's state as hyperglycemic.[14] The same risk applies to insulin pumps, ventilators, and other AI-controlled devices.[12]
Fourth, ransomware-driven AI disruption can knock out the data and systems AI depends on. Between January 2016 and December 2021, 374 ransomware attacks on U.S. healthcare organizations exposed the PHI of nearly 42 million patients.[15][17] Across those incidents:
- 44.4% disrupted health care delivery
- 41.7% caused electronic system downtime
- 10.2% led to cancellations of scheduled care
- 4.3% forced ambulance diversion[15]
In AI-enabled hospitals, EHR downtime can cut off the feeds that power clinical decision support. A review of EHR downtime events found 76 patient safety events tied to downtime, with 48% involving lab results and 14% involving medications.[17] Expert analysis also warns that AI outputs can look authoritative, which means staff may trust and act on results shaped by corrupted inputs or delayed inference. That can increase the chance of treatment errors and patient harm.[13]
How healthcare organizations acted on findings through governance
These simulations pointed to cross-functional breakdowns, not just technical flaws.
Hospitals responded by mapping third-party vendor concentration risk, assigning ownership across security, compliance, clinical informatics, and AI governance, and tracking remediation by PHI exposure, clinical use case, device, and supply-chain dependency.
Censinet RiskOps™ can centralize third-party and enterprise risk assessments and route remediation across security, compliance, clinical, and AI governance teams.
Conclusion: Key lessons for healthcare AI resilience across all case studies
Taken together, these case studies point to one clear pattern: adversarial risk moves around. It can hit the model, the workflow, or the third-party AI vendor environment. Image perturbations, structured EHR changes, prompt injection, and infrastructure weaknesses each threaten a different layer. Put plainly, no part of the clinical AI stack gets a free pass.
So yes, technical defenses matter. But they only go so far on their own. Attack simulation has value ONLY when it changes how a system is deployed, where thresholds are set, and how vendors are reviewed. If it ends at the algorithm, it misses the bigger problem.
Another hard truth: adversarial findings don’t stay current for long. A red team result from six months ago may already be out of date if the model was retrained, a vendor changed its API, or a new attack method showed up. That’s why adversarial testing should run as a repeat program, with version-tagged tracking and scheduled retests after any material model or workflow change.[18][19]
Documentation matters just as much as the testing itself. Teams should keep a clear record of:
- the attack scenario
- the affected system
- the model version
- the observed output
- the remediation steps
- the owner
- the retest results
That audit trail helps with retesting, ownership, and risk acceptance. It’s not just there for compliance paperwork.[20]
Governance ownership also needs to be direct. One person should be assigned to approve remediation and accept residual risk. The lesson here is simple: test the model, the workflow, and the vendor chain together. Censinet RiskOps™ can centralize third-party and enterprise risk tracking across the clinical systems, devices, and vendor relationships where adversarial AI risk appears.
FAQs
How do adversarial attacks affect healthcare AI in practice?
Adversarial attacks can throw healthcare AI off course by tweaking inputs or poisoning training data in ways clinicians may not notice.
In day-to-day use, that can mean a diagnostic system misses a serious condition, a care team sends staff or beds to the wrong patients, or a tool suggests a medication plan that isn’t safe. And here’s what makes this so hard: these attacks can look like ordinary data bias instead of foul play.
That makes them easy to miss for 6 to 12 months. During that time, the damage can spread across patient safety, clinician trust, and the day-to-day stability of healthcare operations.
Which healthcare AI systems are most vulnerable?
Healthcare AI is easy to shake because it often depends on small, specialized datasets, a small set of commercial foundation models, and hard-to-audit training setups like federated learning.
Some systems face more danger than others.
- Radiology AI (CNNs) can be thrown off by tiny pixel changes that a person might not even notice.
- Clinical documentation LLMs are open to prompt injection, which can steer outputs in the wrong direction.
- Life-critical decision systems - such as organ allocation and crisis triage tools - carry the highest stakes when something goes wrong.
That mix is what makes healthcare AI such a high-pressure space: limited data, black-box model choices, and systems that may affect care when every second counts.
What should hospitals test beyond model accuracy?
Beyond model accuracy, hospitals should test how well a model holds up under attack so clinical systems can handle real-world manipulation.
That means running adversarial input simulations, checking boundary conditions, verifying data integrity, and looking for system anomalies. It also means testing for workflow abuse, such as prompt injection, and monitoring over time for model drift or other unexpected behavior.
Validation should go beyond technical testing alone. It also needs governance to help manage risks tied to patient data and clinical decision-making.